Page last updated: 2024-09-05

organophosphonates and Glycogen Storage Disease Type I

organophosphonates has been researched along with Glycogen Storage Disease Type I in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Koeberl, DD; Lian, B; Liao, XH; Lim, A; Masamune, H; Refetoff, S; Tran, B; Waskowicz, LR; Yen, PM; Zhou, J	1

Other Studies

1 other study(ies) available for organophosphonates and Glycogen Storage Disease Type I

Article	Year
A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia. Thyroid : official journal of the American Thyroid Association, 2019, Volume: 29, Issue:8 Topics: Animals; Autophagy; Disease Models, Animal; Fatty Acids; Fatty Liver; Glucose-6-Phosphatase; Glycogen; Glycogen Storage Disease Type I; Liver; Mice; Mice, Knockout; Mitochondria, Liver; Organelle Biogenesis; Organophosphonates; Oxidation-Reduction; Thyroid Hormone Receptors beta; Triglycerides	2019

Article

Year

A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia.

Thyroid : official journal of the American Thyroid Association, 2019, Volume: 29, Issue:8

Topics: Animals; Autophagy; Disease Models, Animal; Fatty Acids; Fatty Liver; Glucose-6-Phosphatase; Glycogen; Glycogen Storage Disease Type I; Liver; Mice; Mice, Knockout; Mitochondria, Liver; Organelle Biogenesis; Organophosphonates; Oxidation-Reduction; Thyroid Hormone Receptors beta; Triglycerides

2019